Skip to main navigation
Skip to search
Skip to main content
University of Edinburgh Research Explorer Home
Help & FAQ
Home
Research output
Profiles
Research units
Projects
Datasets
Prizes
Activities
Press/Media
Equipment
Search by expertise, name or affiliation
MRC Centre for Reproductive Health at the University of Edinburgh
Pollard, Jeffrey
(Principal Investigator)
Deanery of Clinical Sciences
Overview
Fingerprint
Research output
(2)
Project Details
Status
Finished
Effective start/end date
12/09/16
→
11/09/22
Funding
Medical Research Council:
£1,726,882.00
View all
View less
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Malignant Neoplasm
Medicine and Dentistry
100%
Adolescence
Medicine and Dentistry
88%
Cohort Analysis
Medicine and Dentistry
88%
Obstetrics
Medicine and Dentistry
88%
Endometrial Hyperplasia
Medicine and Dentistry
88%
Cumulative Incidence
Medicine and Dentistry
35%
Hysterectomy
Medicine and Dentistry
29%
Uterine Cancer
Medicine and Dentistry
23%
Research output
Research output per year
2024
2024
2024
2
Article
Research output per year
Research output per year
Live birth and maternity outcome in childhood and adolescent cancer survivors under 18 years at diagnosis: a 40-year population-based cohort study
Wallace, W. H.
,
Kelsey, T. W.
,
Morrison, D.
&
Anderson, R. A.
,
Nov 2024
,
In:
British Journal of Cancer.
131
,
8
,
p. 1309-1319
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Adolescence
100%
Obstetrics
100%
Malignant Neoplasm
100%
Cohort Analysis
100%
Population
50%
Diagnosis and management of endometrial hyperplasia: A UK national audit of adherence to national guidance 2012–2020
Henderson, I.
,
Black, N.
,
Khattak, H.
,
UKARCOG Working Group Authors
,
Gupta, J. K.
&
Rimmer, M. P.
,
29 Feb 2024
,
In:
PLoS Medicine.
21
,
2
, e1004346.
Research output
:
Contribution to journal
›
Article
›
peer-review
Open Access
File
Endometrial Hyperplasia
100%
Hysterectomy
33%
Uterine Cancer
26%
Malignant Neoplasm
13%
Shared Decision Making
6%